Found 5 matching trials
MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011) PHASE1 This study will determine whether MK-4827 can be safely administered in com...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment PHASE3 Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Show More Location
Azienda Ospedaliera Spedali Civili
Learn More & Join Trial
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib PHASE2 Carcinosarcomas (CS) (malignant mixed Müllerian tumors) are highly aggressi...
Show More Learn More & Join Trial
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer PHASE1 This pilot study will assess the feasibility of using an implantable microd...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer PHASE3 Atezolizumab in this study is expected to have a positive benefit-risk prof...
Show More Location
Grand Hôpital de Charleroi
Learn More & Join Trial